The Centre is urging states and Union Territories to speed up legal metrology reforms. This includes moving from a licensing system to a re...

President Donald Trump's executive order on powerful AI models has collapsed. Allies in Silicon Valley reportedly convinced the president t...

US President Donald Trump said he had postponed the signing of an executive order on artificial intelligence with top CEOs at the White Hou...

The Indian Patent Office has denied a secondary patent for AbbVie's Hepatitis C drug Maviret. This decision ensures continued access to aff...

The soccer coach had blocked himself from sportsbooks by the time he found prediction markets.

Concerns are mounting in India over the UK-India Free Trade Agreement's potential impact on access to affordable medicines. Experts fear th...

Aurobindo Pharma will manufacture and supply long-acting injectable HIV treatment, cabotegravir, across 133 countries through a voluntary l...

Dr. Reddy’s has partnered with Gilead Sciences to manufacture and market the HIV drug Lenacapavir in India and 120 other countries. The agr...

The Ministry of Road Transport and Highways (MoRTH) on Saturday informed that as many as 58 citizen-centric services related to driving lic...

A voluntary licence (VL) is an authorisation given by the patent holder to a generic company to produce a patented drug while a compulsory ...

Eli Lilly & Company declined the applications on both the occasion, citing the reason that it is really challenging for them to sign volunt...

Lily has issued voluntary licenses for Barcitinib to six Indian drug makers besides Natco, these include- Sun Pharma, Cipla, Dr Reddy's, Lu...

The immediate focus has to be on connecting with the right global companies to facilitate technology transfer and voluntary licenses to Ind...

"Simple waiving of patents for vaccines is not enough for increased and free availability of Vaccines in India,” it said in a statement.The...

The Hyderabad-based firm said it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company fo...

MSD entered into a voluntary licensing agreement with five Indian drug makers including Sun Pharma, Cipla, Dr. Reddy’s, Emcure and Hetero f...

Remdesivir is approved in India for restricted emergency use for the treatment of suspected or laboratory-confirmed COVID-19 in adults and ...